Alternative transcription increases isoform complexity in Long Non-Coding RNAs and alters their functions in cancer
Open Access
- 1 October 2025
- journal article
- review article
- Published by KEAI Publishing in Non-coding RNA Research
- Vol. 14, 38-50
Abstract
Transcriptional start and end variance, a less-explored aspect of lncRNA biology, is a critical determinant of isoform diversity in human RNA. While alternative splicing (AS) has been extensively studied as a mechanism of isoform generation, differences in transcriptional start and termination site usage—whether from distinct promoters or varying initiation events at the same core promoter—contribute more to isoform diversity than alternative splicing. In the context of long non-coding RNAs (lncRNAs), even subtle alterations to transcriptional start and end sites can induce significant changes in the structural and functional capacities of individual lncRNA isoforms.Keywords
Funding Information
- Cancer Research UK Beatson Institute
- British Skin Foundation (004_S_19)
- Cancer Research UK (A31287, A29802)
This publication has 185 references indexed in Scilit:
- Long noncoding RNAs are substrates for cytoplasmic capping enzymeFEBS Letters, 2023
- MALAT1: A Promising Therapeutic Target for the Treatment of Metastatic Colorectal CancerBiochemical Pharmacology, 2021
- CRISPR Interference (CRISPRi) and CRISPR Activation (CRISPRa) to Explore the Oncogenic lncRNA Network2021
- Knocking Down Long Noncoding RNAs Using Antisense Oligonucleotide Gapmers2020
- Retracted: lncRNA CCAT1 contributes to the growth and invasion of gastric cancer via targeting miR‐219‐1Journal of Cellular Biochemistry, 2019
- Long non-coding RNA PVT1 interacts with MYC and its downstream molecules to synergistically promote tumorigenesisCellular and Molecular Life Sciences, 2019
- Cytoplasmic functions of long noncoding RNAsWIREs RNA, 2018
- Targeted heat activation of HSP promoters in the skin of mammalian animals and humansCell Stress and Chaperones, 2018
- Targeting Long Noncoding RNA with Antisense Oligonucleotide Technology as Cancer Therapeutics2016
- CAGE (Cap Analysis of Gene Expression): A Protocol for the Detection of Promoter and Transcriptional Networks2011